GT-969

N/A

Report date: 2026/02/25 20:02:36
NMEFirst In Class

Base Information

Drug NameGT-969
Drug Alias NameGT-969GT969
ClassificationSmall molecules > Molecular Glue
Mechanisms of ActionProto-oncogene vav degraders
TargetsProto-oncogene vav
Therapy Area/IndicationsInflammatory Bowel Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGluetacs Therapeutics (Shanghai) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGluetacs Therapeutics (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammatory Bowel Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A